FDA approves Cervarix, GlaxoSmithKline’s cervical cancer vaccine

GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine.